ARCHIVES

Micafungin Bests Fluconazole In Phase III Antifungal Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

NCAB, De Vita Rap Tobacco Industry For Targeting Blacks, Hispanics

October 24, 1986

STI-571 Effects Are Lasting Against GI Stromal Tumors

July 26, 2002

NDA n Vp-16 Goes to Advisory Committee Sept. 30

August 27, 1982

ACS Urges Practice Of Insurance Exclusion End Under Reform

February 5, 1993

NIH Investigation Clear Gallo Of Charge He Stole Aids Virus

October 12, 1990

Feral Mouse Colony Recompetition Given Concept Approval

November 16, 1990